ArticleDiagnostics (Basel, Switzerland)2021

Longitudinal Monitoring of Plasma Circulating Tumour DNA Enables the Prediction of Early Relapse in Patients with Non-Hodgkin Lymphoma: A Case Series.

Hongyan Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.